基于患者的医疗保险人群药物紊乱诊断分析。
A patient-based analysis of drug disorder diagnoses in the Medicare population.
作者信息
Cartwright W S, Ingster L M
机构信息
Center for Substance Abuse Treatment, Rockville, MD 20857.
出版信息
Health Care Financ Rev. 1993 Winter;15(2):89-101.
This article utilizes the Part A Medicare provider analysis and review (MEDPAR) file for fiscal year (FY) 1987. The discharge records were organized into a patient-based record that included alcohol, drug, and mental (ADM) disorder diagnoses as well as measures of resource use. The authors find that there are substantially higher costs of health care incurred by the drug disorder diagnosed population. Those of the Medicare population diagnosed with drug disorders had longer lengths of stay (LOSs), higher hospital charges, and more discharges. Costs increased monotonically as the number of drug diagnoses increased. Overlap of mental and alcohol problems is presented for the drug disorder diagnosed population.
本文使用了1987财年医疗保险A部分的医疗服务提供者分析与审查（MEDPAR）文件。出院记录被整理成基于患者的记录，其中包括酒精、药物和精神（ADM）障碍诊断以及资源使用情况的衡量指标。作者发现，被诊断患有药物障碍的人群产生的医疗保健成本要高得多。那些被诊断患有药物障碍的医疗保险人群住院时间更长、医院收费更高、出院次数更多。随着药物诊断数量的增加，成本呈单调上升趋势。文中还呈现了被诊断患有药物障碍人群中精神和酒精问题的重叠情况。
Zotero 插件